Abstract
We present a case of a female child who had developed progressive skin tightening of whole body, sclerodactyly, and severe contracture of all joints with restricted opening of mouth with disease onset at 6 weeks of life. The child also had anemia, failure to thrive, recurrent diarrhea, and ascites. Skin biopsy revealed characteristic histopathological features suggestive of scleroderma. Echocardiography revealed thrombus in the right atrium extending to inferior vena cava. Serological markers (antinuclear antibody, antiscl 70, anti-double-stranded DNA, anticentromere antibody) were negative. To our knowledge, this case of scleroderma with disease onset at 6 weeks of life could possibly be among youngest cases reported in the literature. Also, thrombosis in inferior vena cava in a child with scleroderma is being reported for the first time.
References
Zulian F (2008) Systemic Sclerosis and Localized Scleroderma in Childhood. Rheum Dis Clin North Am 34(1):239–255
Scalapino K, Arkachaisri T, Lucas M, Fertig N, Helfrich DJ, Londino AV Jr, Steen VD, Medsger TA Jr (2006) Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol 33(5):1004–1013
Zulian F, Woo P, Athreya BH, Laxer RM, Medsger TA Jr, Lehman TJ, Cerinic MM, Martini G, Ravelli A, Russo R, Cuttica R, de Oliveira SK, Denton CP, Cozzi F, Foeldvari I, Ruperto N (2007) The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum 57(2):203–212
Sato S, Ishida W, Takehara K (2003) A case of juvenile systemic sclerosis with disease onset at six months old. Clin Rheumatol 22(2):162–163
Jansen T, Romiti R (2000) Progeria infantum (Hutchinson-Gilford syndrome) associated with scleroderma-like lesions and acro-osteolysis: a case report and brief review of the literature. Pediatr Dermatol 17(4):282–285
Sevenants L, Wouters C, De Sandre-Giovannoli A, Devlieger H, Devriendt K, van den Oord JJ, Marien K, Lévy N, Morren MA (2005) Tight skin and limited joint movements as early presentation of Hutchinson-Gilford progeria in a 7-week-old infant. Eur J Pediatr 164(5):283–286
Silver RM (1991) Clinical aspects of systemic sclerosis (scleroderma). Ann Rheum Dis 50:846–853
Cohen S (1980) The gastrointestinal manifestations of scleroderma: pathogenesis and management (clinical conference). Gastroenterology 79:155–166
Cobden I, Axon AT, Ghoneim AT, McGoldrick J, Rowell NR (1980) Small intestinal bacterial growth in systemic sclerosis. Clin Exp Dermatol 5:37–42
Young MA, Rose S, Reynolds JC (1996) Gastrointestinal manifestation of scleroderma. Rheum Dis Clin North Am 22:797–823
Morel Z, Benadón E, Faugier E, Maldonado MR (2009) Clinical characteristics of children with scleroderma in a referral hospital. Reumatol Clin 5(3):158–162
Fennell RHJ, Rodnan GP, Vazquez JJ (1962) Variability of tissue-localizing properties of serum from patients with different disease states. Lab Invest 11:24–31
Beck JS, Anderson JR, Gray KG, Rowell NR (1963) Antinuclear and precipitating autoantibodies in progressive systemic sclerosis. Lancet 2(7319):1188–1190
Solomon DH, Kavanaugh AJ, Schur PH (2002) The American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 47(4):434–444
Martini G, Foeldvari I, Russo R, Cuttica R, Eberhard A, Ravelli A, Lehman TJ, de Oliveira SK, Susic G, Lyskina G, Nemcova D, Sundel R, Falcini F, Girschick H, Lotito AP, Buoncompagni A, Sztajnbok F, Al-Mayouf SM, Orbàn I, Ferri C, Athreya BH, Woo P, Zulian F (2006) Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. Arthritis Rheum 54(12):3971–3978
Della Rossa A, Valentini G, Bombardieri S, Bencivelli W, Silman AJ, D’Angelo S, Cerinic MM, Belch JF, Black CM, Becvar R, Bruhlman P, Cozzi F, Czirják L, Drosos AA, Dziankowska B, Ferri C, Gabrielli A, Giacomelli R, Hayem G, Inanc M, McHugh NJ, Nielsen H, Scorza R, Tirri E, van den Hoogen FH, Vlachoyiannopoulos PG (2001) European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Ann Rheum Dis 60:585–591
Leak A, Patel KJ, Tuddenham EG, Pearson JD, Woo P (1990) Axillary vein thrombosis in adolescent onset systemic sclerosis. Ann Rheum Dis 49(7):557–559
Bonam SR (2006) Isolated renal thrombotic microangiopathy as an initial presentation of scleroderma without other systemic manifestations of the disease. Available on URL:http://www.kidney.org/news/meetings/clinical/pdf/2006SCM-AbstractsTopicList.pdf. Accessed 28 June 2010
Hebbar M, Lassalle P, Delneste Y, Hatron PY, Devulder B, Tonnel AB, Janin A (1997) Assessment of anti-endothelial cell antibodies in systemic sclerosis and Sjogren’s syndrome. Ann Rheum Dis 56:230–234
Ihn H, Sato S, Fujimoto M, Igarashi A, Yazawa N, Kubo M, Kikuchi K, Takehara K, Tamaki K (2000) Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis. Clin Exp Immunol 119:203–209
Renaudineau Y, Revelen R, Levy Y, Salojin K, Gilburg B, Shoenfeld Y, Youinou P (1999) Anti-endothelial cell antibodies in systemic sclerosis. Clin Diagn Lab Immunol 6(2):156–160
Assous N, Allanore Y, Batteux F, Meune C, Toulon P, Weill B, Kahan A (2005) Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury. Clin Exp Rheumatol 23(2):199–204
Pope JE, Thompson A (2000) The frequency and significance of anticardiolipin antibodies in scleroderma. J Rheumatol 27:1450–1452
Merkel PA, Chang Y, Pierangeli SS, Convery K, Harris EN, Polisson RP (1996) The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 101(6):576–583
Ihn H, Sato S, Fujimoto M, Kikuchi K, Igarashi A, Soma Y, Tamaki K, Takehara K (1996) Measurement of anticardiolipin antibodies by ELISA using beta 2-glycoprotein I (beta 2-GPI) in systemic sclerosis. Clin Exp Immunol 105(3):475–479
Herrick AL, Heaney M, Hollis S, Jayson MI (1994) Anticardiolipin, anticentromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischaemia. Ann Rheum Dis 53:540–542
Lima J, Fonollosa V, Fernández-Cortijo J, Ordi J, Cuenca R, Khamashta MA, Vilardell M, Simeón CP, Picó M (1991) Platelet activation, endothelial cell dysfunction in the absence of anticardiolipin antibodies in systemic sclerosis. J Rheumatol 18(12):1833–1836
Madej-Pilarczyk A, Rosiska-Borkowska D, Rkawek J, Marchel M, Szalus E, Jablonska S, Hausmanowa-Petrusewicz I (2009) Progeroid syndrome with scleroderma-like skin changes associated with homozygous R435C LMNA mutation. Am J Genet 149(11):2387–2392
Hennekam RC (2006) Hutchinson-Gilford progeria syndrome: review of the phenotype. Am J Med Genet A 140(23):2603–2624
Esterly NB, McKusick VA (1971) Stiff skin syndrome. Pediatrics 47:360–369
Jablonska S, Blaszczyk M (2004) Stiff skin syndrome is highly heterogeneous, and congenital fascial dystrophy is its distinct subset. Pediatr Dermatol 21:508–510
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mishra, N., Shrestha, D., Poudyal, R.B. et al. Atypical presentation of scleroderma in infancy. Rheumatol Int 32, 1069–1074 (2012). https://doi.org/10.1007/s00296-011-1803-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-011-1803-4